Duncan Batty, Trustee




Duncan was awarded a Ph.D in Synthetic Organic Chemistry from University College London. Following Post-Doctoral Fellowships at the University of Illinois at Chicago and a CNRS ‘Poste Rouge’ at the Universite d’Orsay, Paris, he has spent most of his professional life in Pharmaceutical Research, working on a variety of disease conditions including cancer and pain.


Diagnosed with Alkaptonuria as a toddler, he has been receiving treatment for the effects of AKU since 1996 and has been prescribed nitisinone continuously since 2008. He has a younger brother with AKU and three older non-affected siblings.
Duncan has been associated with the AKU for over 10 yrs and is currently member of the TSC scientific advisory committee for the DevelopAKUre consortium.




AKU Twitter

AKU Blog

Rare Disease Day 2019
14-Mar-2019

Rare Disease Day is an international day designed to raise awareness to the public and those.. ...more

Cambridge Half Marathon 2019: On the Day
08-Mar-2019

Last Sunday our two runners, Ana and Katja, both completed the Cambridge Half Marathon. They rai.. ...more

Cambridge Half Marathon 2019: Meet the Runners
22-Feb-2019

The Cambridge Half Marathon is Next Sunday. On the 3rd March our two runners will tackle the roa.. ...more

Final meeting of DevelopAKUre and the 11th Scientific workshop on AKU – Siena 2019
15-Feb-2019

The AKU Society has just come back from a hectic week in the beautiful Italian city of Siena.. ...more

SONIA 2 - Last patients
22-Jan-2019

On the 18th January, the last SONIA 2 (Suitability of Nitisinone In Alkaptonuria 2) patients.. ...more